[Skip to Navigation]
July 2017

Relationship Between the American Academy of Pediatrics and Infant Formula Companies

Author Affiliations
  • 1Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
  • 2The Herman and Walter Children's Hospital at Sinai, Sinai Hospital, Baltimore, Maryland
JAMA Pediatr. 2017;171(7):613-614. doi:10.1001/jamapediatrics.2017.1257

In 2005, the board of directors of the American Academy of Pediatrics (AAP) adopted a policy supporting relationships with companies that, “through their products, activities, and/or their philosophy, enhance the quality of life for children and their families and are aligned with the AAP’s values and mission” (https://www.aap.org/en-us/about-the-aap/aap-leadership/Documents/20-IndustryRelations.pdf). In doing so, the organization chose to apply a higher standard than simply asking whether corporate funding can be put to good use. Under this policy, the AAP should reassess its engagement with companies that sell infant formula.

Add or change institution